FDA.reportPublic FDA data

PancrePlus

Manufacturer
MWI/VetOne | Neogen Corporation-Mercer | Scientific Protein Laboritories LLC
Effective date
2023-12-13
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:42:39

Label at a glance#

ProductPancrePlus
Active ingredientPANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE
Label structure11 sections

Storage and handling

Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).

Label contents#

Full prescribing information#

DESCRIPTION SECTION

PancrePlus

Tablets

Pancreatic Enzyme Concentrate

For use in animals only.

Keep out of reach of children.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

CONTAINS: Each tablet contains a minimum of:

COMPONENTS

Lipase........................................9,000 USP units

Protease...................................57,000 USP units

Amylase....................................64,000 USP units

DESCRIPTION:

DESCRIPTION SECTION

PancrePlusis a pancreatic enzyme concentrate of porcine origin. It is indicated for use as a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

PRECAUTIONS:

PRECAUTIONS SECTION

Discontinue use in animals with symptoms of sensitivity or allergy.

SPL UNCLASSIFIED SECTION

MADE IN USA of U/S. and imported materials

DOSAGE & ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

Average Dose/meal:

Dogs: 2-3 tablets

Cats: 1/2-1 tablet

STORAGE:

STORAGE AND HANDLING SECTION

Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).

WARNINGS SECTION

TAKE TIME

OBSERVE LABEL DIRECTIONS

SPL UNCLASSIFIED SECTION

Questions? Call 800-525-2022 or toll-free 800-621-8829

Distributed by: MWI

Boise, ID 83705

www.VetOne.net

Manufactured by:

Neogen Corporation

Lexington, KY 40511

PRINCIPAL DISPLAY PANEL PancrePlus Tablets 100 Tablet Bottle

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 13985-051-75

100 Tablets

VETone®

PancrePlus

Tablets

Pancreatic Enzyme Concentrate

For use in animals only.

Keep out of reach of children.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

V1 501048 Net Contents: 100 Tablets

PancrePlus Tablets 100ctPancrePlus Tablets 100ct

PRINCIPAL DISPLAY PANEL PancrePlus Tablets 500 Tablet Bottle

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 13985-051-77

500 Tablets

VETone®

PancrePlus

Tablets

Pancreatic Enzyme Concentrate

For use in animals only.

Keep out of reach of children.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

V1 502048 Net Contents: 500 Tablets

PancrePlus Tablets 500ctPancrePlus Tablets 500ct

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1421001lipase 9,000 UNT / amylase 64,000 UNT / protease 57,000 UNT Oral TabletPSN4
1423489PancrePlus 9000 UNT / 64,000 UNT / 57,000 UNT Oral TabletPSN4
1423489amylase 64000 UNT / lipase 9000 UNT / protease 57000 UNT Oral Tablet [PancrePlus]SBD4
1421001amylase 64000 UNT / lipase 9000 UNT / protease 57000 UNT Oral TabletSCD4
1421001amylase 64,000 UNT / protease 57,000 UNT / lipase 9,000 UNT Oral TabletSY4
1421001amylases 64,000 UNT / endopeptidases 57,000 UNT / lipase 9000 UNT Oral TabletSY4
1423489PancrePlus (amylase 64,000 UNT / protease 57,000 UNT / lipase 9,000 UNT) Oral TabletSY4
1423489PancrePlus (amylases 64,000 UNT / endopeptidases 57,000 UNT / lipase 9,000 UNT) Oral TabletSY4

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0b1603b8-969e-b082-f6f5-ad66d8a6ea8aProduct name220200325
19041f15-771b-3d3a-88fc-f5e2d079cd6dProduct name220200325
1987d950-08e4-4b70-adeb-fb67a71142abProduct name220200325
8825ddf7-1520-4680-b0ee-684e2fa73672Product name220200325
267a6f34-90b4-2f48-3063-4f505d06a7beProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
13985-051-75PancrePlus100 in 1 BOTTLE, PLASTICTABLET1004
13985-051-77PancrePlus500 in 1 BOTTLE, PLASTICTABLET5004

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
13985-051PANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE]42 package rows20231214_94322aaf-e9f3-4f20-a5f1-6e1edb91bac2.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PANCRELIPASE AMYLASEACTIVE INGREDIENTYOJ58O116E1
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932O1
PANCRELIPASE PROTEASEACTIVE INGREDIENT3560D81V501
PANCRELIPASE AMYLASEACTIVE MOIETYYOJ58O116E1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932O1
PANCRELIPASE PROTEASEACTIVE MOIETY3560D81V501
ALPHA-TOCOPHEROLINACTIVE INGREDIENTH4N855PNZ11
VITAMIN AINACTIVE INGREDIENT81G40H8B0T1
VITAMIN DINACTIVE INGREDIENT9VU1KI44GP1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
13985-05113985-051-75, 13985-051-77

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
PANCRELIPASE LIPASE8MYC33932OACTIB
PANCRELIPASE PROTEASE3560D81V50ACTIB
PANCRELIPASE AMYLASEYOJ58O116EACTIB

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 10 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1SOLUTION / ORAL1.05 mg/1mlExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1OINTMENT / TOPICALNAExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1SYSTEM / TOPICAL0.1 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1TABLET, EXTENDED RELEASE / ORAL4 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1CAPSULE / ORAL16 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1FILM, SOLUBLE / BUCCAL0.07 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1TABLET, FILM COATED / ORAL246 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1TABLET, CHEWABLE / ORAL0.1 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1TABLET / ORAL2 mgExact identifier — unii candidate
10 equally ranked IID candidates
ALPHA-TOCOPHEROL.ALPHA.-TOCOPHEROLH4N855PNZ1INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS0.64 mgExact identifier — unii candidate
10 equally ranked IID candidates

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.